Antioxidant Properties and Vasorelaxant Mechanism of Aqueous Extract of Ricinodendron heudelotii (Euphorbiaceae)
BioMed Research International · 2024
DOI: 10.1155/2024/3435974 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2024. Verfasst von Jacquy Joyce Wanche Kojom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biology and Physiology Faculty of Sciences University of Douala, PO Box 24157, Douala, Cameroon. Hauptthemen laut MEDLINE: Plant Extracts, Antioxidants, Vasodilator Agents, Rats, Wistar. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ricinodendron heudelotii is a plant of the Euphorbiaceae family, used in traditional medicine to treat numerous diseases, including high blood pressure. The aim of this study is to evaluate the antioxidant and vasorelaxant effects of the aqueous extract of the stem bark of R. heudelotii . The pharmacological studies were carried out using the aqueous extract obtained by infusion. The antioxidant capacity of R. heudelotii was assessed by in vitro tests with DPPH (2,2‐diphenyl‐1‐picryl‐hydrazyl), ABTS (2,2 ′ ‐azino‐bis (3‐ethylbenz‐thiazoline‐6‐sulfonic acid), iron‐reducing capacity (FRAP), and inhibition of nitric oxide (NO) release. In vitro studies, the aortic rings obtained from adult Wistar albino rats of both sexes were used to determine the vasorelaxant effects of the extract of R. heudelotii on the NO and prostacyclin (PGI2) pathways as well as its involvement on various potassium channels were determined on intact or naked fragments of rat aorta precontracted with phenylephrine (10 -6 M) or KCl (60 mM). The aqueous extract of R. heudelotii exhibited a remarkable DPPH (EC 50 : 1.68 μ g/mL) and ABTS (EC 50 : 106.30 μ g/mL) and nitric oxide (53.71% inhibition at 1000 μ g/mL) radical scavenging activities as well as reducing power (absorbance of 1.56 at 1000 μ g/mL). The nitric oxide inhibitor, N G ‐nitro‐L‐arginine methyl ester (L‐NAME), and prostacyclin inhibitor, indomethacin, significantly attenuated the vasodilatory effect of R. heudelotii . Tetraethylammonium could not inhibit the vasodilatory effect of the extract, unlike glibenclamide and barium chloride. Ricinodendron heudelotii extract possesses antioxidant properties and vasorelaxing effect linked to endothelium‐related factors, and this relaxation was partially mediated mainly through the inhibition of K ir and K ATP channels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Biology and Physiology Faculty of Sciences University of Douala, PO Box 24157, Douala, Cameroon.
- Department of Biological Sciences Faculty of Medicine and Pharmaceutical Science University of Douala, PO Box 2701, Douala, Cameroon.
ORCID-Profile: Jacquy Joyce Wanche Kojom, Calvin Zangueu Bogning, Edwige Laure Lappa, Christelle Stéphanie Sonfack, Augustine Nkojap Kuinze, Gisèle Etamé-Loé, Alain Bertrand Dongmo
Zitieren
APA
Kojom, J. J. W., Bogning, C. Z., Lappa, E. L., Sonfack, C. S., Kuinze, A. N., Etamé-Loé, G., & Dongmo, A. B. (2024). Antioxidant Properties and Vasorelaxant Mechanism of Aqueous Extract of Ricinodendron heudelotii (Euphorbiaceae). BioMed Research International. https://doi.org/10.1155/2024/3435974
Vancouver
Kojom JJW, Bogning CZ, Lappa EL, Sonfack CS, Kuinze AN, Etamé-Loé G, et al. Antioxidant Properties and Vasorelaxant Mechanism of Aqueous Extract of Ricinodendron heudelotii (Euphorbiaceae). BioMed Research International. 2024. doi:10.1155/2024/3435974
BibTeX
@article{Kojom2024,
author = {Kojom, Jacquy Joyce Wanche and Bogning, Calvin Zangueu and Lappa, Edwige Laure and Sonfack, Christelle Stéphanie and Kuinze, Augustine Nkojap and Etamé-Loé, Gisèle and Dongmo, Alain Bertrand},
title = {Antioxidant Properties and Vasorelaxant Mechanism of Aqueous Extract of Ricinodendron heudelotii (Euphorbiaceae)},
journal = {BioMed Research International},
year = {2024},
doi = {10.1155/2024/3435974}
}
EUVIMED